HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia
Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom’s macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal to...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/2020/6516037 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832553947553857536 |
---|---|
author | Mark R. Wallace |
author_facet | Mark R. Wallace |
author_sort | Mark R. Wallace |
collection | DOAJ |
description | Ibrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom’s macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal toxicity as compared to traditional chemotherapy, infections have emerged as a major complication of therapy. While fungal infections have been the most problematic (including CNS aspergillosis), zoster, hepatitis B reactivation, and chronic hepatitis E have been reported in association with ibrutinib therapy. This report describes a case of herpes encephalitis in an 86-year-old Waldenstrom’s patient receiving ibrutinib and speculates as to whether this late life encephalitis may have been related to ibrutinib. |
format | Article |
id | doaj-art-6f1e12cd5cba45edbb5c56c9d6ec7bc7 |
institution | Kabale University |
issn | 2090-6625 2090-6633 |
language | English |
publishDate | 2020-01-01 |
publisher | Wiley |
record_format | Article |
series | Case Reports in Infectious Diseases |
spelling | doaj-art-6f1e12cd5cba45edbb5c56c9d6ec7bc72025-02-03T05:52:44ZengWileyCase Reports in Infectious Diseases2090-66252090-66332020-01-01202010.1155/2020/65160376516037HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s MacroglobulinemiaMark R. Wallace0Skagit Valley Hospital, 360 Hospital Parkway, My Vernon, WA 98273, USAIbrutinib is a major new addition to the therapeutic armamentarium for chronic lymphocytic leukemia, mantle cell lymphoma, Waldenstrom’s macroglobulinemia, and chronic graft versus host disease. Though ibrutinib has proven to be a revolutionary new small molecule agent, and has relatively minimal toxicity as compared to traditional chemotherapy, infections have emerged as a major complication of therapy. While fungal infections have been the most problematic (including CNS aspergillosis), zoster, hepatitis B reactivation, and chronic hepatitis E have been reported in association with ibrutinib therapy. This report describes a case of herpes encephalitis in an 86-year-old Waldenstrom’s patient receiving ibrutinib and speculates as to whether this late life encephalitis may have been related to ibrutinib.http://dx.doi.org/10.1155/2020/6516037 |
spellingShingle | Mark R. Wallace HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia Case Reports in Infectious Diseases |
title | HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia |
title_full | HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia |
title_fullStr | HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia |
title_full_unstemmed | HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia |
title_short | HSV-1 Encephalitis in an Elderly Man Receiving Ibrutinib for Waldenstrom’s Macroglobulinemia |
title_sort | hsv 1 encephalitis in an elderly man receiving ibrutinib for waldenstrom s macroglobulinemia |
url | http://dx.doi.org/10.1155/2020/6516037 |
work_keys_str_mv | AT markrwallace hsv1encephalitisinanelderlymanreceivingibrutinibforwaldenstromsmacroglobulinemia |